SR9011 Raw Material Powder For Bodybuilding CAS:1379686-29-9
SR9011 represents a cutting-edge, experimental compound that has garnered significant interest within the advanced bodybuilding and biohacking communities. Unlike traditional anabolic steroids or SARMs, SR9011 operates through a novel and sophisticated mechanism of action, targeting the very core of our cellular energy regulation and circadian biology. This detailed examination will explore what SR9011 is, its unique features, potential applications, purported benefits, and the critical considerations surrounding its use, all while emphasizing its status as a research chemical not intended for human consumption.
What is SR9011?
SR9011 is a synthetic agonist (activator) of the Rev-Erbα protein, which is a critical nuclear receptor and transcription factor. Rev-Erbα is a key component of the body's circadian clock, the internal biological rhythm that regulates sleep-wake cycles, metabolism, and numerous other physiological processes. It was initially developed by Professor Thomas Burris and his team at The Scripps Research Institute as a research tool to study metabolic diseases, circadian disorders, and inflammation.
In its raw material form for "research purposes," SR9011 is a fine powder. Its fundamental action is to bind to and activate Rev-Erbα proteins in various tissues, including the liver, muscle, and brain. This activation suppresses the expression of specific genes involved in inflammation and lipid (fat) production while simultaneously promoting genes responsible for mitochondrial biogenesis and oxidative metabolism.
Key Features of SR9011
1.Novel Mechanism of Action (MoA): Its MoA is entirely distinct from anabolic agents. It does not bind to androgen receptors. Instead, it works by modulating gene expression related to the circadian clock and energy homeostasis.
2.Non-Hormonal: SR9011 is not a hormone and does not directly influence testosterone, estrogen, or other hormonal pathways. This theoretically eliminates the risk of androgenic side effects like hair loss, gynecomastia, or prostate issues.
3.Pro-Metabolic: Its primary effect is to dramatically enhance the body's metabolic rate by increasing the number and efficiency of mitochondria (the powerhouses of the cell) and promoting fat oxidation.
4.Poor Oral Bioavailability: A critical feature is its very low bioavailability when taken orally. It is extensively metabolized by the liver (first-pass metabolism) before reaching systemic circulation. This has led researchers to explore alternative administration routes, primarily subcutaneous injection.
5.Research Chemical Status: It is crucial to underscore that SR9011 has not undergone human clinical trials for safety or efficacy. All available data is pre-clinical, derived from animal studies (primarily mice). Its effects and long-term risks in humans are entirely unknown.
Proposed Applications in Bodybuilding
Within the bodybuilding context, researchers are interested in SR9011 for its potential to manipulate metabolism and body composition.
●Cutting and Fat Loss: The most prominent proposed application is during a cutting phase. Its ability to drastically increase metabolic rate and shift the body's fuel preference towards fat oxidation makes it a compound of interest for achieving extreme leanness and muscle definition.
●Endurance Enhancement: By boosting mitochondrial density, SR9011 could potentially increase aerobic capacity and stamina. This would allow athletes to perform longer, more intense cardio sessions, further contributing to the caloric deficit needed for fat loss.
●Muscle Preservation: Some animal data suggests that activation of Rev-Erbα may have a protective effect on muscle tissue during catabolic states. Theoretically, this could help preserve lean muscle mass while in a significant caloric deficit, a primary goal for bodybuilders during a cut.
●Cholesterol Management: Early research indicates that SR9011 may improve lipid profiles by reducing LDL (bad) cholesterol and increasing HDL (good) cholesterol, though this is a secondary consideration for most athletes.
Purported Benefits (Based on Pre-Clinical Data)
It is vital to interpret these benefits with extreme caution, as they are not proven in humans.
●Accelerated Fat Loss: The dramatic increase in basal metabolic rate would create a substantial energy deficit, forcing the body to mobilize and burn stored adipose tissue at an accelerated pace.
●Increased Energy Expenditure: Users report a significant and constant feeling of internal thermogenesis, akin to a potent stimulant but without the central nervous system effects like jitters or anxiety.
●Enhanced Athletic Performance: Improved mitochondrial function could lead to better endurance, faster recovery between sets, and an increased ability to handle high-volume training.
●Improved Insulin Sensitivity: By promoting glucose uptake into muscle cells for energy, SR9011 may enhance insulin sensitivity, which is beneficial for nutrient partitioning and overall metabolic health.
●Anti-Inflammatory Effects: Activation of Rev-Erbα has been shown to reduce expression of pro-inflammatory genes, which may aid in recovery and joint health.
Dosage, Administration, and Half-Life
Due to the lack of human data, any discussion of dosage is speculative and derived from anecdotal reports from the research community.
●Dosage: Anecdotal research doses typically range from 10 mg to 30 mg per day. It is common to start at the lower end of this range (e.g., 10 mg/day) to assess tolerance.
●Administration: Given its poor oral bioavailability, the most common method of administration in research settings is subcutaneous injection. The powder is reconstituted with a solvent like bacteriostatic water or PEG-400. Intranasal administration has also been explored by some, though its efficacy is less documented.
●Half-Life: The half-life of SR9011 is believed to be relatively short, estimated at 4 to 6 hours based on its pharmacokinetic profile. This necessitates multiple daily administrations (e.g., every 6-8 hours) to maintain stable plasma concentrations and continuous activation of Rev-Erbα receptors throughout the day.
Cycle Protocol and Post-Cycle Considerations
A typical research cycle for SR9011 is kept relatively short due to the complete lack of long-term safety data.
●Cycle Length: Cycles often last 6 to 8 weeks. Extending beyond this point is not advised due to the unknown potential for off-target effects or disruption of the natural circadian rhythm.
●PCT (Post-Cycle Therapy): Since SR9011 is non-hormonal and does not suppress the hypothalamic-pituitary-testicular axis (HPTA) like steroids or SARMs, a traditional PCT protocol (e.g., with SERMs like Nolvadex or Clomid) is generally considered unnecessary. Its mechanism does not directly impact testosterone production.
●Post-Cycle Considerations: The primary concern after ceasing SR9011 is not hormonal recovery but metabolic readjustment. The body's metabolism has been artificially elevated, and a sudden cessation could lead to a rapid rebound effect, including swift weight regain as the metabolic rate normalizes. A prudent approach involves gradually tapering the dosage down over the final week of the cycle and strictly maintaining a controlled diet and training regimen post-cycle to mitigate rebound fat gain.
Critical Caveats and Potential Risks
The allure of SR9011's mechanism is strong, but the risks are substantial and cannot be overstated.
1.Unknown Human Safety Profile: This is the single most important factor. Toxicity, organ damage, and other long-term side effects are completely unknown.
2.Circadian Rhythm Disruption: As a core circadian clock protein agonist, tampering with Rev-Erbα could have unforeseen consequences on sleep architecture, hormone secretion rhythms, and other vital circadian-controlled functions. Ironically, some user reports indicate severe insomnia as a side effect.
3.Purity and Sourcing: Sourcing a raw research chemical powder carries immense risk. There is no guarantee of purity, concentration, or sterility, especially when intended for injection. Contaminants can cause severe infections or health complications.
4.Administration Risks: Subcutaneous injection, if not performed with sterile technique, carries risks of infection, abscesses, and tissue damage.
Clinical Data
|
Trade names |
SR9011 |
|
CAS |
1379686-29-9 |
|
Molar mass |
479.04 |
|
MF |
C23H31ClN4O3S |
|
Purity |
Above 98% |
|
Apprarance |
White Cyrstalline Powder |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-15871669785
Conclusion
SR9011 raw material powder is a fascinating research chemical that operates on the frontier of metabolic science. Its potential to revolutionize fat loss and endurance through circadian biology is a compelling subject for scientific inquiry. However, it remains exactly that-a research chemical. The leap from promising murine studies to safe and effective human application is vast and fraught with unknown dangers. For the bodybuilding community, it represents a high-risk, experimental frontier whose purported benefits are currently overshadowed by significant potential health risks and a complete absence of human data. Extreme caution, thorough personal research, and a clear understanding of its experimental status are an absolute prerequisite for any individual considering its use.
Hot Tags: sr9011 raw material powder for bodybuilding cas:1379686-29-9, China sr9011 raw material powder for bodybuilding cas:1379686-29-9 manufacturers, suppliers, factory, AC 262 Selective androgen receptor modulator, LGD4033, MK2866, GW501516 Ergogenic performance enhancing, RAD150 Promotes muscle growth, RAD140 increase lean muscle mass
